Molecular Medicine
A section of Biomolecules (ISSN 2218-273X).
Section Information
The Section Molecular Medicine of the open access journal, Biomolecules (ISSN 2218-273X) publishes both high-impact areas of review articles and exceptional original research contributions. The areas of interest include but are not limited to molecular pathogenesis, molecular diagnosis and new therapeutical approaches, underpinning of human disorders, encompassing hereditary, neoplastic, metabolic, neurological, psychological, psychiatric, cardiovascular, immunological, renal, and infectious diseases. Research studies based on omics approaches are also welcome.
We invite you to submit your contributions focusing on but not restricted to:
We invite you to submit your contributions focusing on but not restricted to:
- Molecular pathogenesis
- Molecular diagnosis
- Molecular basis of diseases
- Experimental therapeutic approaches based on novel pathomechanisms
- Gene and protein networks regulating pathogenetic processes
- Epigenetic mechanisms regulating pathogenesis of human diseases
- Cellular signaling mechanisms regulating pathogenetic processes
- Systems biology approaches of molecular pathogenesis
- Bioinformatics and translational aspects of approaches of molecular pathogenesis
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Skeletal Muscle Homeostasis and Regeneration: 2nd Edition (Deadline: 15 January 2026)
- Inositol Phosphates in Health and Disease, 2nd Edition (Deadline: 31 January 2026)
- Mitochondrial Medicine: A Themed Issue in Honor of Prof. Dr. Carl A. Pinkert (Deadline: 31 January 2026)
- New Insights into Kidney Disease Development and Therapy Strategies (Deadline: 31 January 2026)
- Molecular Advances in Rett Syndrome and Other Chromatin Related Disorders (Deadline: 31 January 2026)
- Pharmacology of Cardiovascular Diseases (Deadline: 31 January 2026)
- Focus on Perineural Invasion in Pancreatic Cancer (Deadline: 31 January 2026)
- Developmental Biology of the Kidney: From Molecular Mechanisms to Congenital Disorders (Deadline: 31 January 2026)
- Molecular Mechanisms, Novel Diagnostics and Treatments of Gynecologic Cancer (Deadline: 31 January 2026)
- Cellular and Molecular Mechanisms in Cardiopathy and Therapeutic Strategies (Deadline: 31 January 2026)
- Endometriosis: Molecular Pathogenesis and Translational Implications (Deadline: 31 January 2026)
- Alcohol Consumption as a Cardiovascular Risk Factor: Focusing on Molecular Mechanisms (Deadline: 31 January 2026)
- Pathogenesis and Targeted Therapy of Neurodegenerative Diseases (Deadline: 31 January 2026)
- Advances in Antiviral Drug Development (Deadline: 15 February 2026)
- Recent Advances in Immunotherapy for Mesothelioma (Deadline: 15 February 2026)
- Heterocyclic Compounds as Novel Anti-Cancer Agents and Their Mechanisms of Action (Deadline: 28 February 2026)
- Molecular and Cellular Mechanisms in Anti-Thrombosis (Deadline: 28 February 2026)
- Exploring Novel Molecular Pathways and Emerging Treatments for Neuromuscular Disorders (Deadline: 28 February 2026)
- Inflammatory Mechanisms and Molecular Targets in Neurological Disorders: Effects of Neuroprotective Drugs (Deadline: 28 February 2026)
- Chronic Heart Failure: From Molecular Mechanisms to Therapies Strategies (Deadline: 28 February 2026)
- Molecular Mechanisms and Drug Research in Alzheimer’s Disease (Deadline: 28 February 2026)
- Exploring the Pathophysiology of Epilepsy: Metabolic Mechanisms and Therapeutic Potential (Deadline: 28 February 2026)
- Alcohol-Related Nervous System Damage and Disease: From Mechanisms to Therapies (Deadline: 14 March 2026)
- Molecular Insights into Treatment and Prognosis of Autoimmune Bullous Diseases (Deadline: 15 March 2026)
- Molecular Insights into Bronchiolitis Obliterans (Deadline: 15 March 2026)
- Advances in Lysosomal Disorders: From Molecular Mechanisms to Diagnosis (Deadline: 29 March 2026)
- Esophageal Diseases: Molecular Basis and Therapeutic Approaches (Deadline: 31 March 2026)
- Breast Cancer: Molecular Pathology, Drug Resistance and Novel Treatment Strategies (Deadline: 31 March 2026)
- Novel Antimicrobial Strategies for Animal Health (Deadline: 31 March 2026)
- Metabolic Pathways, COVID-19 and Other Viral Acute Respiratory Infections: Mechanisms and Clinical Implications: 2nd Edition (Deadline: 31 March 2026)
- New Discoveries in the Field of Neuropharmacology (Deadline: 31 March 2026)
- Advanced Therapeutic Strategies for Hormone-Dependent Cancers (Deadline: 31 March 2026)
- Exploring the Molecular and Cellular Mechanisms of Pulmonary Arterial Hypertension (Deadline: 31 March 2026)
- The Role of Heparin in Blood (Deadline: 31 March 2026)
- Citrin Deficiency: Molecular Pathogenesis and Novel Targets for Therapy (Deadline: 31 March 2026)
- Synthetic Biology's Potential to Address Undruggable Targets and Difficult-to-Treat Diseases (Deadline: 31 March 2026)
- Molecular Aspects of Diseases Origin and Development (Deadline: 20 April 2026)
- Advances in Melanoma Targeted Therapy (Deadline: 30 April 2026)
- Roles of Alpha-1 Antitrypsin in Human Health and Disease Models (Deadline: 30 April 2026)
- Molecular Mechanisms and Therapeutic Targets in Leukaemia (Deadline: 30 April 2026)
- Biomolecular Sciences and Precision Medicine in Vascular Disease (Deadline: 30 April 2026)
- Enzyme Inhibitors as Novel Medicinal Agents: From Current to Future Applications (Deadline: 30 April 2026)
- Cell Death and Clearance (Deadline: 30 April 2026)
- Metabolic Syndrome and Type 2 Diabetes: From Molecular Pathogenesis to Novel Therapies (Deadline: 30 April 2026)
- The Immune Response to Severe Trauma (Deadline: 30 April 2026)
- Application of Spectral Analysis in Disease Diagnosis and Treatment (Deadline: 30 April 2026)
- Pathophysiological Insights into Congenital Myasthenic Syndromes (Deadline: 30 April 2026)
- Phytochemicals: Bioactivity in Disease Prevention, Anti-Inflammation, and Animal/Human Health (Deadline: 30 April 2026)
- Molecular Mechanisms, Pathogenesis, and Treatment of Cardiovascular Diseases (Deadline: 30 April 2026)
- Advances in the Molecular Mechanisms of Inflammatory Arthritis and Inflammation-Related Bone Changes: 2nd Edition (Deadline: 30 April 2026)
- Molecular Mechanisms and Current Treatment Strategy of Sarcomas (Deadline: 30 April 2026)
- Notch and Its Regulation in Health and Disease (Deadline: 20 May 2026)
- Tissue Calcification in Normal and Pathological Environments (Deadline: 31 May 2026)
- Redox Balance and Proteostasis Surveillance in Neurodegenerative Disorders (Deadline: 31 May 2026)
- Bioactive Molecules in the Control of Oxidative Stress and Oxidative Stress-Related Diseases (Deadline: 31 May 2026)
- Nonalcoholic Fatty Liver Disease: From Molecular Mechanisms to Therapeutic Approaches (Deadline: 31 May 2026)
- Liver Damage and Associated Metabolic Disorders (Deadline: 31 May 2026)
- Dysregulated Cytokine Signals in Human Disease (Deadline: 31 May 2026)
- Advances in Metabolomics in Health and Disease (Deadline: 31 May 2026)
- Advancing Innovations in Biomedical Research for Translational Applications (Deadline: 31 May 2026)
- Bench and Bedside: Molecular Insights and Neuroprotective Strategies for Stroke (Deadline: 31 May 2026)
- Impact of Systemic Inflammation on Neuroinflammation, Neurodegenerative Diseases and Mental Disorders (Deadline: 31 May 2026)
- Immune Microenvironment in Cancer: Myeloid Cells and Therapeutic Insights (Deadline: 31 May 2026)
- Advances and Emerging Strategies in Gene Therapy (Deadline: 31 May 2026)
- Cellular Stress, Inflammation, and Metabolic Dysfunction in the Progression of MASLD (Deadline: 31 May 2026)
- Innate Immunity and Inflammation: From Molecular Mechanisms to Therapeutic Applications (Deadline: 31 May 2026)
- Skin Diseases: Molecular Pathogenesis and Therapeutic Approaches (Deadline: 31 May 2026)
- Bone Tissue Morphology: From Pathophysiological Mechanisms to Regenerative Strategies (Deadline: 31 May 2026)
- Current and Future Molecular Insights into Hematological Diseases: From Diagnosis to Therapy (Deadline: 31 May 2026)
- Molecular Pathogenesis and Emerging Therapeutic Targets and Strategies in Huntington’s Disease (Deadline: 31 May 2026)
- Advances in Nano-Based Drug Delivery Systems (Deadline: 1 June 2026)
- Aldehyde Metabolism and Innate Immune Signaling in Cardiovascular Disease: From Pathogenesis to Regeneration (Deadline: 1 June 2026)
- Oral Cancer: New Advances in Therapies (Deadline: 20 June 2026)
- WDFY1 in Immune Regulation and Disease: From Molecular Mechanisms to Therapeutic Applications (Deadline: 20 June 2026)
- Pulmonary Fibrosis: From Molecular Mechanism to Therapeutic Targets (Deadline: 25 June 2026)
- Molecular Pathology, Diagnostics, and Therapeutics of Lung Disease (Deadline: 30 June 2026)
- Novel Insights into Epithelial Mesenchymal Transition (EMT) in Cancer (Deadline: 30 June 2026)
- Molecular Mechanism of Viral Infection and Host Immunity in Transplantation (Deadline: 30 June 2026)
- Recent Advances in Cellular and Non-Cellular Treatment of Stroke (Deadline: 20 July 2026)
- Advances in Type 2 Diabetes: Molecular Mechanisms and Therapeutic Innovations (Deadline: 20 July 2026)
- Developmental-Related Brain Disorders (Deadline: 20 July 2026)
- Functions and Mechanisms of Protective Biomolecules in Metabolic Diseases (Deadline: 20 July 2026)
- Wound Repair and Regeneration: From Molecular and Cellular Mechanisms to New Approaches (Deadline: 20 July 2026)
- Signaling Pathways of 5-HT Receptors in Neuropsychiatric Disorders (Deadline: 20 July 2026)
- Molecular Insights into Retinal Biology: Focus on Inflammation, Metabolism, and Retinal Dysfunction (Deadline: 24 July 2026)
- Cardiometabolic Disease: Molecular Basis and Therapeutic Approaches (Deadline: 31 July 2026)
- Hepatic Stellate Cells and Immune Microenvironment in Hepatocellular Carcinoma (Deadline: 31 July 2026)
- CRISPR-Directed Gene Editing: Molecular Approaches to Cancer Therapeutics (Deadline: 31 July 2026)
- Exploration of Drug Targets for Liver Fibrosis Based on Hepatic Stellate Cells and Extracellular Matrix Remodeling (Deadline: 31 July 2026)
- Metabolic and Signaling Networks in Therapy Resistance (Deadline: 31 July 2026)
- Protein Spreading in Neurodegenerative Diseases: From Mechanisms to Therapeutics (Deadline: 31 July 2026)
- TRP Channels in Cardiovascular and Inflammatory Disease, 2nd Edition (Deadline: 20 August 2026)
- Glycosylation: Cutting-Edge Approach to Targeted Therapy in Cancer (Deadline: 30 August 2026)
- The Molecular and Cellular Mechanisms in Multiple Sclerosis (Deadline: 30 August 2026)
- New Insights into Cardiometabolic Diseases, 2nd Edition (Deadline: 31 August 2026)
- New Insights into Mechanisms and Therapeutics for Cardiovascular Disorders: 2nd Edition (Deadline: 31 August 2026)
- Mechanistic Insights of Retinal Diseases and Directions for New Therapeutics (Deadline: 31 August 2026)
- Molecular Mechanisms and Microenvironmental Regulation in Bone-Related Diseases and Muscle Atrophy (Deadline: 1 September 2026)
- The Heme Oxygenase/Biliverdin Reductase System in Human Health and Disease: New Molecular Insights and Therapeutic Targets (Deadline: 1 September 2026)
- Alcohol-Related Organ Damage: Mechanisms, Outcomes, and Treatment Modalities (Deadline: 30 September 2026)
- Ferroptosis and Cuproptosis: Mechanism and Crosstalk in Cancer, Neurodegeneration, and Metabolic Syndrome (Deadline: 30 September 2026)
- Choline and Its Supplementation in Human Health and Disease (Deadline: 30 September 2026)
- The Impact of Blood Pressure on Neurological Outcomes (Deadline: 30 September 2026)
- The Function of Stromal Cells in Gastrointestinal (GI) Diseases (Deadline: 23 October 2026)
- Novel Molecular Targets for Beta Cell Regeneration and Diabetes Therapy (Deadline: 30 October 2026)
- Molecular and Genetic Basis of Hormonal Signaling and Inter-Organ Crosstalk in Steatotic Liver Disease (Deadline: 30 November 2026)
- Cellular and Molecular Basis of Parasite Infection (Deadline: 31 December 2026)
Topical Collections
Following topical collections within this section are currently open for submissions:
- Drug-Phototherapy (Closed)
- Emerging Targets and Tissue Engineering Strategies for Repair and Regeneration (Closed)
- Feature Papers in Section 'Molecular Medicine'
- Metabolomics and Integrated Multi-Omics in Health and Disease
- Natural and Synthetic Compounds in Neurodegenerative Disorders (Closed)
- Recent Advances in Cancer Immunotherapy
- Recent Advances in Pancreatic Cancer (Closed)
